Skip to main content

2025 IDWeek Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

322 Views

A1. Novel Agents

Poster Session: Novel Agents

(P-1209) Efficacy of β-lactam Enhancer Based Zidebactam-Cefepime Combination (WCK 5222) versus Meropenem in Adults with Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) in a Global, Randomized, Double-blind, Phase 3 Trial

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Co-Author(s)

PG

Pencho Genov, MD

University Multiprofile Hospital for Active Treatment "Kanev"
Ruse, Ruse, Bulgaria
BM

Boris Mladenov, MD

University Multiprofile Hospital for Active Teatment and Emergency Medicine - Pirogov (UMHATEM N.I.PIROGOV)
Sofia, Sofiya, Bulgaria
DS

Donatas Slaitas, MD

Republican Vilnius University hospital
Vilnius, Vilniaus Apskritis, Lithuania
MG

Mario Gonzalez, MD

Santos Research Center, Corp
Tampa, Florida, United States
PM

Pratikshit Mahajan, MD

Supe Heart and Diabetes Hospital And Research Centre
Nashik, Maharashtra, India
HH

Haihui Huang, MD

Fudan University Huashan Hospital, Institute of Antibiotics
Shanghai, Shanghai, China
DS

Denise Sharp, BSc Hons

Wockhardt
Aurangabad, Maharashtra, India
AJ

Alena Jandourek, MD

Wockhardt
Aurangabad, Maharashtra, India

Presenting Author(s)

Lily Llorens, PhD (she/her/hers)

VP Statistics and Data Management
Wockhardt
Aurangabad, Maharashtra, India

Co-Author(s)

DF

David Friedland, MD

Wockhardt
Aurangabad, Maharashtra, India
PI

Piotr Iwanowski, MD

Wockhardt
Aurangabad, Maharashtra, India
RG

Ranjeet Gutte, MBA

Wockhardt
Aurangabad, Maharashtra, India
MP

Mahesh Patel, PhD

Chief Mentor Research and Development
Wockhardt Limited
Mumbai, Maharashtra, India

Co-Author(s)

SB

Sachin Bhagwat, PhD

Chief Scientific Officer
Wockhardt Limited
Mumbai, Maharashtra, India